Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration

Circulation

Volumn 102, Issue 1, 2000, Pages 61-66

  Sin, Don D ^a   Logan, Alexander G ^a   Fitzgerald, Fabia S ^a   Liu, Peter P ^a   Bradley, T Douglas ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Clinical trials; Heart assist devices; Sleep apnea, central

Indexed keywords

ADULT; AGED; ARTICLE; CHEYNE STOKES BREATHING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART ASSIST DEVICE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0034604274     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.1.61     Document Type: Article

References (31)

1. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
2. Lechat P, Packer M, Chalon S, et al. Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double blind placebo-controlled, randomized trials. Circulation. 1998;98:1184-1191.
3. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomized trial. Lancet. 1999;353:9-13.
4. CONSENSUS Trial Study Group. Effects of enalapril on mortality in chronic congestive heart failure. N Engl J Med. 1987;316:819-823.
5. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325:303-310.
6. Changes in mortality from heart failure: United States, 1980-1995. MMWR Morb Mortal Wkly Rep. 1998;47:633-637.
7. Ho KK, Anderson KM, Kannel WB, et al. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993;88:107-115.
8. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: trends in incidence and survival in a 10-year period. Arch Intern Med. 1999;159:29-34.
9. Bradley TD, Holloway RM, McLaughlin PR, et al. Cardiac output response to continuous positive pressure airway pressure in congestive heart failure. Am Rev Respir Dis. 1992;145:377-382.
10. Naughton MT, Rahman MA, Hara K, et al. Effect of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure. Circulation. 1995;91: 1725-1731.
11. Lenique F, Habis M, Lafaso F, et al. Ventilatory and hemodynamic effects of continuous positive airway pressure in left heart failure. Am J Respir Crit Care Med. 1997;155:500-505.
12. Tkacova R, Liu PP, Naughton MT, et al. Effects of continuous positive airway pressure on atrial natriuretic peptide and mitral regurgitant fraction in patients with heart failure and central sleep apnea. J Am Coll Cardiol. 1997;30:739-745.
13. Javaheri S, Parker TJ, Liming JD, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure: types and their prevalences, consequences, and presentations. Circulation. 1998;97:2154-2159.
14. Findley LJ, Zwillich CW, Ancoli-Israel S, et al. Cheyne-Stokes breathing during sleep in patients with left ventricular heart failure. South Med J. 1985;78:11-15.
15. Lanfranchi PA, Braghiroli A, Bosimini E, et al. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation. 1999;99:1435-1440.
16. Hanly PJ, Zuberi-Khokhar NS. Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med. 1996;153:272-276.
17. Naughton MT, Benard DC, Liu PP, et al. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med. 1995;152:473-479.
18. van de Borne P, Oren R, Abouassaly C, et al. Effect of Cheyne-Stokes respiration on muscle sympathetic nerve activity in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1998;81:432-436.
19. Franklin KA, Sandstrom E, Johansson G, et al. Hemodynamics, cerebral circulation, and oxygen saturation in Cheyne-Stokes respiration. J Appl Physiol. 1997;83:1184-1191.
20. Solin P, Bergin P, Richardson M, et al. Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation. 1999;99: 1574-1579.
21. Tkacova R, Hall MJ, Liu PP, et al. Left ventricular volume in patients with heart failure and Cheyne-Stokes respiration during sleep. Am J Respir Crit Care Med. 1997;156:1549-1555.
22. Naughton MT, Liu PP, Benard DC, et al. Treatment of congestive heart failure and Cheyne-Stokes Respiration during sleep by continuous positive airway pressure. Am J Respir Crit Care Med. 1995;151:92-97.
23. Rechtschaffen A, Kales AA. A Manual of Standardized Terminology, Technique and Scoring System for Sleep Stages of Human Subjects. Washington, DC: National Institutes of Health; 1968. Publication No. 204.
24. Chada TS, Watson H, Birch S, et al. Validation of respiratory inductive plethysmography using different calibration procedures. Am Rev Respir Dis. 1982;125:644-649.
25. Sin D, Fitzgerald F, Parker JD, et al. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med. 1999;160:1101-1106.
26. Butler G, Naughton MT, Rahman A, et al. Acute effects of continuous positive airway pressure on heart rate variability in congestive heart failure. J Am Coll Cardiol. 1995;25:672-679.
27. Cintron G, Johnson G, Francis G, et al, for the Ve-HEFT VA Cooperative Studies Group. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. Circulation. 1993;87(suppl VI):VI-17-VI-23.
28. Leung RS, Tkacova R, Bradley TD. Letter to the editor. Lancet. 1999; 354:1212-1213.
29. Kienle GS, Kiene H. The powerful placebo effect: fact or fiction? J Clin Epidemiol. 1997;50:1311-1318.
30. Floras JS, Bradley TD. Sleep apnoea: a therapeutic target in congestive heart failure. Eur Heart J. 1998;19:820-821.
31. Lipkin DP. Sleep-disordered breathing in chronic stable heart failure. Lancet. 1999;354:531-532.